LongeVC
Ticinolongevc.com
Overview
LongeVC is an international venture capital firm investing in an ageless future. Through supporting exceptional early stage founders, their mission is to bring breakthrough biotech to market — the science that will change lives and transform our health. They curate an ecosystem of biotech and longevity-focused companies, connecting founders with a global network of thought leaders.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Unnatural Products | Mar 2026 | Series B | Co-investor |
| Valink Therapeutics | Oct 2025 | Early Funding | Co-investor |
| Trogenix | Oct 2025 | Series A | Co-investor |
| Constructive Bio | Mar 2025 | Series A Extension | Co-investor |
| SiPhox Health | Mar 2025 | Series A Extension | Co-investor |
Key People
Sergey Jakimov
Managing Partner
Garri Zmudze
General Partner
Artem A. Trotsyuk
Venture Partner
Julie Liu
Venture Partner
Matt Toner
Venture Partner
Timothy E. Morris
Venture Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.